Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €1.71 EUR
Change Today -0.027 / -1.55%
Volume 2.0K
NRST On Other Exchanges
Symbol
Exchange
BrsaItaliana
As of 3:57 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

neurosoft (NRST) Snapshot

Open
€1.71
Previous Close
€1.74
Day High
€1.71
Day Low
€1.71
52 Week High
04/8/15 - €2.38
52 Week Low
11/19/14 - €1.28
Market Cap
43.1M
Average Volume 10 Days
700.0
EPS TTM
€0.11
Shares Outstanding
25.2M
EX-Date
--
P/E TM
16.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for NEUROSOFT (NRST)

Related News

No related news articles were found.

neurosoft (NRST) Related Businessweek News

No Related Businessweek News Found

neurosoft (NRST) Details

Neurosoft Software Production S.A., together with its subsidiaries, designs, develops, customizes, and maintains integrated software systems in the areas of sports betting and gaming analytics, business intelligence, and core factoring in Greece and internationally. It also provides advanced information technology services. The company operates through Factoring and Financials, Sports Betting & Gaming Analytics, Field, Network, and Security segments. The Factoring and Financials segment offers Proxima+, a business factoring software solution to assist factoring companies; Tesla, a Web interface for clients and debtors of a factoring company; and FoLs, an integrated risk management and anti-fraud tool for factoring companies. The Sports Betting & Gaming Analytics segment provides business intelligence solutions, which offer liability monitoring capabilities to betting operators; and Qualytor, a tool that watches the market trends and ensures that the operator stays within acceptable limits. This segment is also developing a book making and pricing tool. The Field segment offers implementation and support services for technologies ranging from fixed access, microwave, optical transport, IT, air-conditioning, and power environments. The Network segment designs and implements new solutions for telecom needs, as well as supports carrier-grade customers with sensitive SLAs. The security segment provides cyber security. The company was founded in 1994 and is based in Athens, Greece.

70 Employees
Last Reported Date: 04/8/15
Founded in 1994

neurosoft (NRST) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

neurosoft (NRST) Key Developments

Neurosoft Software Production Société Anonyme Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2014

Neurosoft Software Production Société Anonyme announced audited consolidated earnings results for the year ended December 31, 2014. For the period, the company reported revenues were €10,271,403 compared to €5,842,269 a year ago. Profit before income taxes was €2,556,197 compared to €1,002,702 a year ago. Net Profit was €2,779,420 compared to €723,362 a year ago. Profit attributable to equity holders of the parent was €2,734,469 compared to €643,026 a year ago. Net cash from operating activities was €1,250,274 compared to €2,402,899 a year ago. Capital expenditure for property, plant and equipment was €986,334 compared to €221,119 a year ago. Net financial debt as of 31 December 2014 for the Group amounts to €1.47 million compared to €1.19 million as of 31 December 2013.

Caputron Medical, LLC. Inks Distribution Agreement with Neurosoft LTD

Caputron Medical announced it has entered into an agreement to distribute Neurosoft products for Transcranial Magnetic Stimulation. The distribution agreement brings Caputron Medical the rights to market the Neuro-MS/D Diagnostic, Therapeutic, and Advanced Therapeutic rTMS stimulators in the United States and Canada. Neurosoft TMS systems combine features and performance not available in any other TMS product, packaged in high-value systems for customers. These unique performance features include an unparalleled high-performance cooling system capable of performing up to 10,000 pulses during one session, a peak magnetic field of up to 4 Tesla and 20 Hz stimulation with 100% intensity. Neurosoft products are used internationally at medical research centers in the study of the non-invasive neuromodulation with applications areas in psychiatry, neurology, cognitive neuroscience, clinical neurophysiology and rehabilitation.

Neurosoft Software Production Société Anonyme to Report Fiscal Year 2014 Results on Apr 06, 2015

Neurosoft Software Production Société Anonyme announced that they will report fiscal year 2014 results at 10:30 AM, E. Europe Standard Time on Apr 06, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NRST:IM €1.71 EUR -0.027

NRST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NRST.
View Industry Companies
 

Industry Analysis

NRST

Industry Average

Valuation NRST Industry Range
Price/Earnings 14.8x
Price/Sales 4.0x
Price/Book 7.7x
Price/Cash Flow 14.8x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROSOFT, please visit www.neurosoft.gr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.